FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Ipsen Gains Accelerated OK for Iqirvo

FDA grants Ipsen accelerated approval for Iqirvo (elafibranor) 80 mg tablets for treating primary biliary cholangitis in combination with ursodeoxycho...

latest-news-card-1
Federal Register

Obstetrics/Reproductive Advisory Panel Renewed

Federal Register notice: FDA announces the renewal of its Obstetrics, Reproductive and Urologic Drugs Advisory Committee for an additional two years.

latest-news-card-1
Federal Register

Arthritis Advisory Panel Renewed for 2 Years

Federal Register notice: FDA announces the renewal of its Arthritis Advisory Committee for an additional two years.

latest-news-card-1
Human Drugs

Emerging Drug Safety Technology Meeting Program

FDA launches an Emerging Drug Safety Technology Meeting (EDSTM) program to assist industry in implementing artificial intelligence activities related ...

latest-news-card-1
Biologics

GSKs Arexvy Gets Expanded Approval

FDA approves an expanded use for GSKs Arexvy (respiratory syncytial virus vaccine, adjuvanted) for preventing RSV lower respiratory tract disease.

latest-news-card-1
Medical Devices

FDA Clears 2 Abbott OTC Glucose Monitors

FDA clears two Abbott 510(k)s for over-the-counter continuous glucose monitoring systems Lingo and Libre Rio.

latest-news-card-1
Human Drugs

FDA Panel Backs Lillys Alzheimers Drug

FDAs Peripheral and Central Nervous System Advisory Committee unanimously votes to recommend the approval of Eli Lillys donanemab-azbt to treat Alzhei...

Medical Devices

Moon Surgicals Maestro Surgical Device Cleared

FDA clears a Moon Surgical 510(k) for its Maestro surgical system.

latest-news-card-1
Human Drugs

Geron Myelodysplastic Syndromes NDA Approved

FDA approves a Geron NDA for Rytelo (imetelstat) for treating certain adult patients with low- to intermediate-1 risk myelodysplastic syndromes.

latest-news-card-1
Federal Register

CDER Proposes to Deny Vanda Hetlioz sNDA

Federal Register notice: CDER posts a proposal to refuse the approval of a supplemental NDA submitted by Vanda Pharmaceuticals for Hetlioz (tasimelteo...